Human Reproduction, Vol. 6, No. 5, pp. 670-671, 1991
© 1991 European Society of Human Reproduction and Embryology
other |
Spontaneous pregnancies in two women with Laron-type dwarfism: are growth hormone and circulating insulin-like growth factor mandatory for induction of ovulation?
Department of Obstetrics and Gynaecology The Chaim Sheba Medical Centre Tel-Hashomer 52621 and Sackler School of Medicine, Tel-Aviv University Israel 1Paediatric Endocrinology Unit, Institute of Endocrinology, The Chaim Sheba Medical Centre Tel-Hashomer 52621 and Sackler School of Medicine, Tel-Aviv University Israel
Correspondence: 2To whom correspondence should be addressed
It has recently been claimed that growth hormone (GH) and insulin-like growth factors have a role in follicular development; different mechanisms of action have been proposed. Of late, many investigators have been led by these findings to use GH and growth hormone-releasing hormone (GHRH) for induction of ovulation, in combination with human menopausal gonadotrophins. It is, however, still doubtful whether or not growth hormones and/or insulin-like growth factors are mandatory for follicular development and fertility. In this study we describe two women with Laron-type dwarfism who lacked insulin-like growth factors and who had spontaneous pregnancies. We also discuss different natural defects in the production and metabolism of growth hormone and insulin-like growth factors in humans, and the fertility performance of the affected females. It is our assumption that GH and systemic insulin-like growth factors may modulate follicular development, but that they are not necessarily mandatory for ovarian follicular development.
Key words: growth hormone/insulin-like growth factors I and II/reproduction/fertilization/Laron dwarfism
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
N. S. Macklon, R. L. Stouffer, L. C. Giudice, and B. C. J. M. Fauser The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization Endocr. Rev., April 1, 2006; 27(2): 170 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Zeleznik, L. Little-Ihrig, and S. Ramasawamy Administration of Insulin-Like Growth Factor I to Rhesus Monkeys Does Not Augment Gonadotropin-Stimulated Ovarian Steroidogenesis J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5722 - 5729. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bachelot, P. Monget, P. Imbert-Bollore, K. Coshigano, J. J. Kopchick, P. A. Kelly, and N. Binart Growth Hormone Is Required for Ovarian Follicular Growth Endocrinology, October 1, 2002; 143(10): 4104 - 4112. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.G.I. van Weering, D.R. Gutknecht, and R. Schats Augmentation of ovarian response by dehydroepiandrosterone Hum. Reprod., July 1, 2001; 16(7): 1537 - 1538. [Full Text] [PDF] |
||||
![]() |
L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice The Insulin-Related Ovarian Regulatory System in Health and Disease Endocr. Rev., August 1, 1999; 20(4): 535 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. M. de Boer, M. van der Meer, E. A. van der Veen, and J. Schoemaker Growth Hormone (GH) Substitution in Hypogonadotropic, GH-Deficient Women Decreases the Follicle-Stimulating Hormone Threshold for Monofollicular Growth J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 590 - 595. [Abstract] [Full Text] |
||||
![]() |
P. Schwarzler, G. Untergasser, M. Hermann, S. Dirnhofer, B. Abendstein, S. Madersbacher, and P. Berger Selective Growth Hormone/Placental Lactogen Gene Transcription and Hormone Production in Pre- and Postmenopausal Human Ovaries J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3337 - 3341. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. I. Sharara and L. C. Giudice Role of Gorwth Hormone in Ovarian Physiology and Onest of Puberty Reproductive Sciences, January 1, 1997; 4(1): 2 - 7. [Abstract] [PDF] |
||||




